KROS
Keros Therapeutics Inc
Price:  
13.41 
USD
Volume:  
414,700.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KROS Relative Valuation

-71.7%
Upside

As of 2025-07-03, the Relative Valuation of Keros Therapeutics Inc (KROS) is 3.80 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.41 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is -71.7%.

The range of the Relative Valuation is 2.79 - 5.62 USD.

Range Selected
Trailing P/E multiples 26.9x - 33.0x 30.0x
Forward P/E multiples 32.5x - 54.2x 43.4x
Fair Price 2.79 - 5.62 3.80
Upside -79.2% - -58.1% -71.7%
13.41 USD
Stock Price
3.80 USD
Fair Price

KROS Relative Valuation - Historical P/E Data

Date P/E
2025-07-02 130.87
2025-07-01 128.65
2025-06-30 128.75
2025-06-27 130.10
2025-06-26 130.29
2025-06-25 131.64
2025-06-24 132.22
2025-06-23 132.70
2025-06-20 130.10
2025-06-18 130.67
2025-06-17 129.81
2025-06-16 131.74
2025-06-13 130.77
2025-06-12 131.54
2025-06-11 132.99
2025-06-10 132.60
2025-06-09 135.88
2025-06-06 145.04
2025-06-05 145.72
2025-06-04 142.92
2025-06-03 144.18
2025-06-02 141.38
2025-05-30 136.46
2025-05-29 135.21
2025-05-28 141.19
2025-05-27 138.39
2025-05-23 140.51
2025-05-22 136.56
2025-05-21 135.40
2025-05-20 136.36
2025-05-19 135.98
2025-05-16 135.69
2025-05-15 135.30
2025-05-14 131.06
2025-05-13 129.90
2025-05-12 132.51
2025-05-09 131.64
2025-05-08 135.21
2025-05-07 132.22
2025-05-06 132.70
2025-05-05 140.37
2025-05-02 141.28
2025-05-01 140.51
2025-04-30 139.26
2025-04-29 139.35
2025-04-28 137.52
2025-04-25 137.04
2025-04-24 139.06
2025-04-23 137.91
2025-04-22 133.95